Fig. 5
From: SNRPD1 confers diagnostic and therapeutic values on breast cancers through cell cycle regulation
Cell viability upon knocking down SNRPD1. a Sequence alignment results showing the target loci of the two siRNAs on SNRPD1. Knocking down efficiency of siRNAs used for silencing SNRPD1 in MCF7 and MDAMB231 cells as assessed using b q-PCR and c western blot. ‘si-1’, ‘si-2’ and ‘si-1 + 2’ each represents siRNA-1, siRNA-2 and their pooled effects. d Normalized cell viability upon SNRPD1 silencing using pooled siRNAs